Pharmacists and Pharmacy Techs: New CE Requirements. Click here for more info.

- Multimedia -

Safe Handling of Hazardous Drugs: Risks and Practical Considerations

Activity Description

For healthcare providers, exposure to hazardous drugs can lead to contamination and uptake. Are you one of those at risk? Consequences of exposure include local reactions, cancer, organ toxicity, fertility problems, genetic damage, and birth defects. Although guidelines for safe handling of hazardous drugs exist, exposures still occur, suggesting that compliance is variable. This activity will review the risk of exposure to hazardous drugs, methods to avoid exposure, and best practices for contamination management.

Learning Objectives

Upon completion of this activity, nurses, pharmacists, and pharmacy technicians will be able to:

  • Define hazardous drugs and negative health effects associated with exposure

  • Identify work practices that present a risk of exposure to hazardous drugs

  • Outline workplace strategies and practices to reduce exposure and prevent contamination from hazardous drugs

  • Describe technological advances that may reduce the exposure of healthcare providers to hazardous drugs during compounding and administration

Faculty

Thomas H. Connor, PhD
Research Biologist
Division of Applied Research and Technology
National Institute for Occupational Safety and Health
Cincinnati, Ohio

Seth Eisenberg, RN, OCN
Professional Practice Coordinator, Infusion Services
Seattle Cancer Care Alliance
Seattle, Washington

Disclosure

It is the policy of ProCE, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Connor and Mr. Eisenberg both report having no relevant affiliations or financial relationships to disclose.
 
Please note: The information and views presented in this CE activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications. Use of drugs and/or devices outside of labeling should be considered experimental. Participants are advised to consult and verify manufacturer product information, the professional literature and use his/her professional judgment in applying the presented information in patient care activities.

CE Accreditation

Release Date: 11-22-2010

Expiration Date: 11-22-2013

Pharmacists and Pharmacy Technicians
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-10-046-H05-P/T has been assigned to this knowledge-based home-study CE activity (initial release date 11-22-10). This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Nurses
CE is provided for this activity through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Wild Iris Medical Education, Inc. is accredited as a provider of continuing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.0 contact hour of nurse CE credit.

Funding

This activity was supported by an unrestricted educational grant from ICU Medical, Inc., and Hospira, Inc.




To Participate

To participate in this Web-based continuing education activity:

1. Review the activity description and objectives.
2. View the activity by clicking on the link below.
3. Take the online post-test and complete the evaluation by clicking the post-test hyperlink on the final slide of the activity (registration will be required).
View this Activity
View as Flash
Download Handouts
Post-Test / Evaluation and CE Statement

To take the post-test, complete the evaluation, and to obtain your CE/CME statement:

  • New User
    Click here to register
  • Existing User / Not Yet Enrolled in this Course
    Click here to enroll
    (previous ProCE user that has NOT yet enrolled in this specific course)
  • Existing User / Already Enrolled in the Course
    Click here
    (To resume taking the post-test OR Reprint CE Statement)

NOTE: If you attended the webinar titled "Safe Handling of Hazardous Drugs: Risks and Practical Considerations" that was held on July 29, September 30, and November 18, 2010 AND received CE credit (i.e. a pharmacist/pharmacy technician CE statement of credit or a nurse CE certificate), you are NOT allowed to receive credit again for this home-study web course.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Click here for ProCE, Inc.'s Privacy Policy.

Copyright © 2002-2012 - ProCE, Inc. - All Rights Reserved
Web Address www.ProCE.com • E-Mail Info@ProCE.com
Phone 630.540.2848 • Fax 630.540.2849